Oculis Holding AG (OCS) Operating Income Growth (1y) (2023 - 2026)
Oculis Holding AG (OCS) Operating Income Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 37.40 Bn | 34.39 Bn | 959.66 Mn | 1,386.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.89% |
| Dec 31, 2025 | -31.02% |
| Sep 30, 2025 | -21.24% |
| Jun 30, 2025 | -0.89% |
| Mar 31, 2025 | -26.51% |
| Dec 31, 2024 | -43.44% |
| Sep 30, 2024 | 99.86% |
| Jun 30, 2024 | -108.06% |
| Mar 31, 2024 | 63.76% |
| Dec 31, 2023 | -19.07% |
| Sep 30, 2023 | -106.16% |
| Jun 30, 2023 | -24.59% |